FITC-BSA (9mg/kg) was injected via the jugular vein in rats. 1 h after the administration, the abdominal cavity was opened, and the abdominal aorta was cut open, slowly infusing the normal saline solution through the jugular vein until the lung tissue became white. The right-lung tissue was embedded with OCT glue, and a frozen section (section thickness 10–15μm) was performed. Tissues were fixed with 4% paraformaldehyde for 15 min, permeated with 0.1% Triton-X for 5 min, and incubated with DAPI (1:50) at 37°C for 30 min. The FITC-BSA exudation in lung tissue was observed under a laser confocal microscope. A 2 cm incision was made along the middle of the abdomen for other rats to select mesenteric fixation with abundant micro-vessels. FITC-BSA was injected into the femoral vein. After 6 minutes, the leakage of FITC-BSA into mesenteric micro-vessels was observed by an inverted microscope (Hamamatsu, Japan).19 (link)